Summit Therapeutics Inc. logo SMMT - Summit Therapeutics Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 14
HOLD 7
SELL 0
STRONG
SELL 0
| PRICE TARGET: $19.00 DETAILS
HIGH: $23.00
LOW: $16.00
MEDIAN: $18.00
CONSENSUS: $19.00
UPSIDE: 14.32%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 9.87
Quick Ratio 9.87
Solvency Ratio -15.754
Cash Ratio 3.09

Valuation Ratios

Ratio Value
Price/Earnings
-12.11
Hist. avg: 8.0
Peers avg: 19.6
PEG Ratio -0.03
Forward PEG -0.03
Price/Book 26.74
Price/Sales 0.00
Price/FCF -54.45
Price/Op Cash Flow -54.56

Debt Ratios

Ratio Value
Debt/Assets 0.0278
Debt/Equity 0.0317
Debt/Capital 0.0307
Long-Term Debt/Capital 0.0000
Financial Leverage 1.14

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -4.424
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.2%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.00
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage -15.46
Capital Expenditure Coverage -491.52
Dividend + Capital Expenditure Coverage -491.52

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -1.444
Debt/Share 0.0207
Cash/Share 0.71
Book Value/Share 0.65
Tangible BV/Share 0.65
Equity/Share 0.65
Operating Cash Flow/Share -0.321
Capital Expenditure/Share 0.001
FCF/Share -0.321

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.986
Price/Fair Value 26.74
Debt/Market Cap 0.0000
Effective Tax Rate 0.0%
Enterprise Value Multiple -11.97